BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23456251)

  • 1. Liver tumors and loco-regional therapy.
    Vogel W
    Wien Med Wochenschr; 2013 Mar; 163(5-6):107-8. PubMed ID: 23456251
    [No Abstract]   [Full Text] [Related]  

  • 2. JAMA PATIENT PAGE. Treatment of Liver Cancer.
    Mokdad AA; Singal AG; Yopp AC
    JAMA; 2016 Jan; 315(1):100. PubMed ID: 26746473
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical value of continuous administration of sorafenib in combination with modified transarterial chemoembolization in patients with unresectable hepatocellular carcinoma.
    Huang YH; Chen W; Li JP; Chen B; Yang JY
    Chin Med J (Engl); 2013 Jan; 126(2):385-6. PubMed ID: 23324295
    [No Abstract]   [Full Text] [Related]  

  • 4. [Resection or interventional treatment of hepatocellular carcinoma: which method for which patient?].
    Lang H; Ricke J; Schlaak J
    Dtsch Med Wochenschr; 2013 Sep; 138(36):1780-4. PubMed ID: 23943578
    [No Abstract]   [Full Text] [Related]  

  • 5. Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Geschwind JF; Chapiro J
    Clin Adv Hematol Oncol; 2016 Aug; 14(8):585-7. PubMed ID: 27487101
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of intermediate-stage hepatocellular carcinoma.
    Finn RS
    Clin Adv Hematol Oncol; 2015 Aug; 13(8):501-3. PubMed ID: 26351811
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of hepatocellular carcinoma: an overview of major findings from meta-analyses.
    Qi X; Zhao Y; Li H; Guo X; Han G
    Oncotarget; 2016 Jun; 7(23):34703-51. PubMed ID: 27167195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma: options for diagnosing and managing a deadly disease.
    Murali AR; Romero-Marrero C; Aucejo F; Menon KV
    Cleve Clin J Med; 2013 Oct; 80(10):645-53. PubMed ID: 24085810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?
    Sacco R; Antonucci M; Bargellini I; Marceglia S; Mismas V; Cabibbo G
    Future Oncol; 2015; 11(17):2371-3. PubMed ID: 26270206
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of hepatocellular carcinoma.
    Del Pozo AC; López P
    Clin Liver Dis; 2007 May; 11(2):305-21. PubMed ID: 17606209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemoembolization techniques for hepatocellular carcinoma in cirrhosis].
    Vetter D; Bronowicki JP; Doffoël M
    Ann Chir; 1998; 52(6):527-34. PubMed ID: 9752502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing localized unresectable hepatocellular carcinoma.
    Narang-Master J; Rizzolo D
    JAAPA; 2015 Jan; 28(1):27-34. PubMed ID: 25486501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major achievements in hepatocellular carcinoma.
    Bruix J; Llovet JM
    Lancet; 2009 Feb; 373(9664):614-6. PubMed ID: 19231618
    [No Abstract]   [Full Text] [Related]  

  • 14. Multidisciplinary Approach in Hepatocellular Carcinoma in a Level II Hospital: The First Decade of Hospital Universitario Fundacion Alcorcon.
    Loinaz Segurola C; LIedó Navarro JL; Burgos Rde L; Martín Ríos D; Ochando Cerdán F; Alonso López S; Martel Villagrán J; Gutiérrez Garcia ML; Fernandez Cebrián JM; Fernández Rodríguez C
    Hepatogastroenterology; 2015 Jun; 62(140):971-7. PubMed ID: 26902039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Considerations of Real Life of Hepatocellular Carcinoma in a Tertiary Center of Brazil.
    Almeida-Carvalho SR; Gomes-Ferraz ML; Loureiro-Matos CA; Benedito-Silva AT; Carvalho-Filho RJ; Renato-Perez R; Miziara-Gonzalez A; Salzedas-Netto AA; Szejnfeld D; D'Ippolito G; Pereira-Lanzoni V; Souza-Silva I
    Ann Hepatol; 2017; 16(2):255-262. PubMed ID: 28233747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstaging hepatocellular carcinoma prior to liver transplantation.
    Gamblin TC; Geller DA
    Liver Transpl; 2005 Dec; 11(12):1466-8. PubMed ID: 16315292
    [No Abstract]   [Full Text] [Related]  

  • 17. Sorafenib combined with TACE in advanced primary hepatocellular carcinoma.
    Cui HZ; Dai GH; Shi Y; Chen L
    Hepatogastroenterology; 2013; 60(122):305-10. PubMed ID: 23574656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma.
    Forner A; Llovet JM; Bruix J
    Lancet; 2012 Mar; 379(9822):1245-55. PubMed ID: 22353262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hepatocellular carcinoma -- experience of a single center.
    Iliescu L; Mindrut E; Grasu M; Orban C; Tanase A; Toma L
    Chirurgia (Bucur); 2014; 109(2):204-7. PubMed ID: 24742411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality therapy and liver transplantation for hepatocellular carcinoma: a 14-year prospective analysis of outcomes.
    Ramanathan R; Sharma A; Lee DD; Behnke M; Bornstein K; Stravitz RT; Sydnor M; Fulcher A; Cotterell A; Posner MP; Fisher RA
    Transplantation; 2014 Jul; 98(1):100-6. PubMed ID: 24503764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.